Core Insights - The company reported a net income per share of $0.29 and Core FFO per share of $2.99 for the full year, reflecting nearly 3% year-over-year growth [1] - For Q4 2025, net income per share was $0.10, while Core FFO per share increased by nearly 6% year-over-year to $0.77 [2] - The company is guiding for approximately 3% Core FFO per share growth at the midpoint for 2026 [3] Lease Renewals and Portfolio Performance - As of December 31, 2025, the company renewed 38 leases totaling 2.6 million square feet, with 27 renewals having no associated tenant improvement work [6] - The average rent spread anticipated on remaining renewals is 14%, with a weighted average total renewal term of 15.7 years [7] - The portfolio's occupancy rate is near historical highs at 97%, with weighted average lease terms of roughly a decade [4] Development Projects - The company has broken ground on a State Crime Lab in Fort Myers, Florida, and a U.S. Courthouse in Flagstaff, Arizona, with expected deliveries in 2026 and 2027 respectively [8] - The FDA Atlanta facility was completed and delivered to the government, with the company receiving $138.1 million in reimbursements related to the project [9] Acquisitions and Financial Guidance - The company completed the acquisition of a three-asset portfolio in Virginia for $44.5 million, with a going-in cash cap rate of approximately 11% [10] - For 2026, the company maintains its Core FFO per share guidance range of $3.05 to $3.12, supported by operational efficiencies and the Virginia acquisition [13] - The acquisition pipeline totals $1.5 billion, with the company monitoring the market for opportunities [13] Balance Sheet and Leverage - Cash leverage is reported at 7.5x, with expectations that remaining FDA Atlanta reimbursements will improve this measure [12] - The medium-term leverage objective is approximately 6x, which is important for improving the company's cost of capital [12]
Easterly Government Properties Q4 Earnings Call Highlights